,
A link between hepatic glucose production and peripheral energy metabolism via hepatokines, Mol Metab, vol.3, pp.531-543, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-01350728
Sweet Sixteenth for ChREBP: Established Roles and Future Goals, Cell Metab, vol.26, pp.324-341, 2017. ,
Liver glucose metabolism in humans, Biosci. Rep, vol.36, 2016. ,
Hormonal and Metabolite Regulation of Hepatic Glucokinase, Annu. Rev. Nutr, vol.36, pp.389-415, 2016. ,
Role of glycogen phosphorylase in liver glycogen metabolism, Molecular Aspects of Medicine, vol.46, pp.34-45, 2015. ,
Elevated Glucose Represses Liver Glucokinase and Induces Its Regulatory Protein to Safeguard Hepatic Phosphate Homeostasis, Diabetes, vol.60, pp.3110-3120, 2011. ,
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace, Journal of Hepatology, vol.56, pp.1384-1391, 2012. ,
, , 2008.
, Large VLDL into Intermediate Density Lipoprotein Particles Contribute to Hyperlipidemia in Glycogen Storage Disease Type 1a, Pediatr Res, vol.63, pp.702-707
Disturbed lipid metabolism in glycogen storage disease type 1, Eur J Pediatr, vol.161, pp.65-69, 2014. ,
,
The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans, J. Clin. Invest, vol.122, pp.2176-2194, 2012. ,
Diabetes-like renal glomerular disease in Fanconi-Bickel syndrome, Pediatr. Nephrol, vol.9, pp.287-291, 1995. ,
Fatty liver disease in diabetes mellitus, Hepatobiliary Surg Nutr, vol.4, pp.101-108, 2015. ,
Enzymatic characterization of four new mutations in the glucose-6 phosphatase (G6PC) gene which cause glycogen storage disease type 1a, Ann. Hum. Genet, vol.63, pp.141-146, 1999. ,
Liver hyperplasia and paradoxical regulation of glycogen metabolism and glucose-sensitive gene expression in GLUT2-null hepatocytes. Further evidence for the existence of a membrane-based glucose release pathway, J. Biol. Chem, vol.275, pp.10930-10936, 2000. ,
The Natural Course of Non-Alcoholic Fatty Liver Disease, 2016. ,
, Int J Mol Sci, vol.17
Advanced glycation end products increase carbohydrate responsive element binding protein expression and promote cancer cell proliferation, Mol. Cell. Endocrinol, vol.395, issue.23, pp.69-78, 2014. ,
The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives, Nat Rev Endocrinol, vol.8, pp.228-236, 2012. ,
Mutation analysis in 24 French patients with glycogen storage disease type 1a, J. Med. Genet, vol.33, pp.358-360, 1996. ,
Rat small intestine is an insulin-sensitive gluconeogenic organ, Diabetes, vol.50, pp.740-746, 2001. ,
Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice, Diabetes, vol.55, pp.2159-2170, 2006. ,
Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver, J. Hepatol, vol.56, pp.199-209, 2012. ,
Peripheral and central glucose sensing in hypoglycemic detection, Physiology (Bethesda), vol.29, pp.314-324, 2014. ,
,
Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease, Cell, vol.167, pp.843-857, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01607311
, , p.24
,
, A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents, 2015.
, , vol.21, pp.27-36
A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism, Mol Metab, vol.6, pp.14-21, 2017. ,
Renal gluconeogenesis: its importance in human glucose homeostasis, Diabetes Care, vol.24, pp.382-391, 2001. ,
Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia, J. Hepatol, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-02339527
Mechanisms by Which Metabolic Reprogramming in GSD1 Liver Generates a Favorable Tumorigenic Environment, Journal of Inborn Errors of Metabolism and Screening, vol.4, 2016. ,
Progressive development of renal cysts in glycogen storage disease type I, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-02339729
, , vol.25, pp.3784-3797
Carbohydrate-response-element-binding protein (ChREBP), vol.432, pp.249-254, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00535587
Normal hepatic glucose production in the absence of GLUT2 reveals an alternative pathway for glucose release from hepatocytes, Proc. Natl. Acad. Sci. U.S.A, vol.95, pp.12317-12321, 1998. ,
Decreased expression of hepatic glucokinase in type 2 diabetes, Mol Metab, vol.4, pp.222-226, 2015. ,
Non-alcoholic fatty liver disease and diabetes, Metabolism, vol.65, pp.1096-1108, 2016. ,
Glycogen storage diseases: a brief review and update on clinical features, genetic abnormalities, pathologic features, and treatment, Ultrastruct Pathol, vol.35, pp.183-196, 2011. ,
Hepatocytes contribute to residual glucose production in a mouse model for glycogen storage disease type Ia, Hepatology, vol.66, pp.2042-2054, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-02339628
Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice, 2006. ,
, Am. J. Physiol. Endocrinol. Metab, vol.291, pp.358-364
Glucagon and regulation of glucose metabolism, American Journal of Physiology -Endocrinology and Metabolism, vol.284, pp.671-678, 2003. ,
Pentose phosphate pathway activity parallels lipogenesis but not antioxidant processes in rat liver, American Journal of Physiology-Endocrinology and Metabolism, vol.314, pp.543-551, 2018. ,
The role of kidney in the inter-organ coordination of endogenous glucose 26 production during fasting, 2018. ,
ChREBP regulates fructoseinduced glucose production independently of insulin signaling, Journal of Clinical Investigation, vol.126, pp.4372-4386, 2016. ,
Necrotic foci, elevated chemokines and infiltrating neutrophils in the liver of glycogen storage disease type Ia, J. Hepatol, vol.48, pp.479-485, 2008. ,
Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of, American College of Medical Genetics and Genomics, vol.16, p.1, 2014. ,
Altered lipid content inhibits autophagic vesicular fusion, FASEB J, vol.24, pp.3052-3065, 2010. ,
Diverse Roles of TGF-?/Smads in Renal Fibrosis and Inflammation, Int J Biol Sci, vol.7, pp.1056-1067, 2011. ,
Diabetes: Should we use fibrates in patients with diabetes and mild CKD?, Nature Reviews Nephrology, vol.8, pp.201-202, 2012. ,
Hormonal regulation of hepatic glucose production in health and disease, Cell Metab, vol.14, pp.9-19, 2011. ,
Autophagy: a new target for nonalcoholic fatty liver disease therapy, Hepat Med, vol.8, pp.27-37, 2016. ,
, , p.27, 2009.
, in Glycogen Storage Disease Type I, Natural Course, and Renopreservative Effects of ACE Inhibition, Clin J Am Soc Nephrol, vol.4, pp.1741-1746
TGF-?/Smad signaling in renal fibrosis, Front Physiol, vol.6, 2015. ,
Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-02339561
,
Glycogenosis type I and diabetes mellitus: a common mechanism for renal dysfunction?, Med. Hypotheses, vol.59, pp.110-114, 2002. ,
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies, Nat Rev Drug Discov, vol.15, pp.249-274, 2016. ,
Control of Blood Glucose in the Absence of Hepatic Glucose Production During Prolonged Fasting in Mice, Diabetes, vol.60, pp.3121-3131, 2011. ,
LRH-1-dependent glucose sensing determines intermediary metabolism in liver, J. Clin. Invest, vol.122, pp.2817-2826, 2012. ,
Liver and kidney metabolism during prolonged starvation, J. Clin. Invest, vol.48, pp.574-583, 1969. ,
Treatment of Diabetic Kidney Disease With Hypertension Control and Renin Angiotensin System Inhibition, Adv Chronic Kidney Dis, vol.25, pp.158-165, 2018. ,
, , 2014.
, Metab. Clin. Exp, vol.63, pp.104-111
Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats, Science, vol.347, pp.1253-1256, 2015. ,
Protein feeding promotes redistribution of endogenous glucose production to the kidney and potentiates its suppression by insulin, Endocrinology, vol.150, pp.616-624, 2009. ,
Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice, J. Clin. Invest, vol.118, pp.829-838, 2008. ,
, , 2015.
Analysis of ChREBP Binding Sites on Male Mouse Liver and White Adipose Chromatin, Endocrinology, vol.156, pp.1982-1994 ,
Glucokinase regulatory protein: complexity at the crossroads of triglyceride and glucose metabolism, Curr. Opin. Lipidol, vol.26, pp.88-95, 2015. ,
, , 2007.
Glycogen storage disease type 1 and diabetes: learning by comparing and contrasting the two disorders, Diabetes Metab, vol.39, pp.377-387, 2013. ,
Glycogen and its metabolism: some new developments and old themes, Biochem. J, vol.441, pp.763-787, 2012. ,
Gut-Brain Glucose Signaling in Energy Homeostasis, Cell Metabolism, vol.25, pp.1231-1242, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-02339600
Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases, HPB (Oxford), vol.12, pp.509-522, 2010. ,
GLUT2, glucose sensing and glucose homeostasis, Diabetologia, vol.58, pp.221-232, 2015. ,
Glucose transporters in the regulation of intestinal, renal, and liver glucose fluxes, Am. J. Physiol, vol.270, pp.541-553, 1996. ,
FIELD Study Investigators, 2012. Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment: the FIELD Study, Diabetes Care, vol.35, pp.218-225 ,
The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation, Proc. Natl. Acad. Sci. U.S.A, vol.106, pp.21660-21665, 2009. ,
Pathophysiology of the diabetic kidney, Compr Physiol, vol.1, pp.1175-1232, 2011. ,
Short-term control of glucokinase activity: role of a regulatory protein, FASEB J, vol.8, pp.414-419, 1994. ,
,
Bezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type Ia, Hum. Mol. Genet, 2018. ,
, , p.2, 2018.
Inborn Errors of Metabolism with Hypoglycemia: Glycogen Storage Diseases and, 2018. ,
, Pediatr. Clin. North Am, vol.65, pp.247-265
Edinburgh Type 2 Diabetes Study Investigators, 2011. Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study, Diabetes Care, vol.34, pp.1139-1144 ,
Defective Hepatic Autophagy in Obesity Promotes ER Stress and Causes Insulin Resistance, Cell Metab, vol.11, pp.467-478, 2010. ,
The angiotensin system mediates renal fibrosis in glycogen storage disease type Ia nephropathy, Kidney Int, vol.73, pp.716-723, 2008. ,